should start to recover, page-6

agree, I think there could be a longterm surprise too.

March finances: Fundamentals look good to me
NPAT: 104.85m for the year, up 79.3% from PCP.

Perhaps just has had a down post merger & being dropped of MSCI.

IMO there's potential for increase in div & sp (& I predict higher than you lol). As far as generics are concerned, once it's sorted & some figures start coming through, imo it will reinforce the positives of the Arrow merger.

HSBC & Commsec have it as a buy atm.